Cita APA

Contreras, C. F., Higham, C. S., Behnert, A., Kim, K., Stieglitz, E., & Tasian, S. K. (2020). Clinical Utilization of Blinatumomab and Inotuzumab Immunotherapy in Children with Relapsed or Refractory B-Acute Lymphoblastic Leukemia. Pediatr Blood Cancer.

Citación estilo Chicago

Contreras, Cristina F., Christine S. Higham, Astrid Behnert, Kailyn Kim, Elliot Stieglitz, and Sarah K. Tasian. "Clinical Utilization of Blinatumomab and Inotuzumab Immunotherapy in Children With Relapsed or Refractory B-Acute Lymphoblastic Leukemia." Pediatr Blood Cancer 2020.

Cita MLA

Contreras, Cristina F., et al. "Clinical Utilization of Blinatumomab and Inotuzumab Immunotherapy in Children With Relapsed or Refractory B-Acute Lymphoblastic Leukemia." Pediatr Blood Cancer 2020.

Nota: a formatação da citação pode não corresponder 100% ao definido pela respectiva norma.